Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24851086 | 0.85 | — | — | |
| SCHEMBL24849086 | 0.76 | — | — | |
| SCHEMBL31409231 | 0.74 | HPRT1 (0.39) | TRPM4ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL10296824 | 0.74 | TRPM4 (0.47) | TRPM4ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL13520751 | 0.71 | NQO1 (0.42) | PGRAHRALDH1A1HSD17B10 | |
| SCHEMBL13520880 | 0.68 | ALOX5 (0.47) | — | |
| SCHEMBL14124778 | 0.67 | ADORA2A (0.51) | TRPM4ALDH1A1HIF1ACYP1B1HSD17B10 | |
| SCHEMBL6527095 | 0.66 | ALDH1A1 (0.40) | AHRALDH1A1HSD17B10CYP1A2CYP2C19 | |
| SCHEMBL22855298 | 0.65 | MGAM (0.39) | ALDH1A1HSD17B10 | |
| SCHEMBL25395389 | 0.64 | TRPM4 (0.37) | TRPM4ALDH1A1HIF1ACYP1B1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11081659-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-08-03 | — | — | US | disclosed |
| US-20190214584-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190214584-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, L1CAM, MCM2 | NR3C1 4137/4885PGR 1039/4885NR3C2 2946/4885 |
| US-11081659-B2 | Organic electroluminescent materials and devices | SOD1, L1CAM, MCM2 | NR3C1 4137/4885PGR 1039/4885NR3C2 2946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.